Guaifenesin Tablet, Extended Release
Product Images NDC 69848-018

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 69848-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14 Count (200000002973 R 00 Final)

Packaging label for Guaifenesin Extended-Release Tablets 1200 mg by Granules USA, Inc. The box highlights 'Maximum Strength' and states the product is an expectorant with 14 extended-release bi-layer tablets. It claims to relieve chest congestion, thin and loosen mucus, and provide immediate and extended release for up to 12 hours. The label shows the actual tablet size and includes drug facts, usage warnings, directions, inactive ingredients, and manufacturer contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.